SC upholds NPPA's Rs 4.6 crore penalty on Sun Pharma

Sun Pharmaceutical Industries Ltd, the sixth-largest generic pharmaceutical manufacturer in the world, had questioned NPPA's demand notice of 2005 for payment of Rs 4.6 crore "to recover the higher price charged in relation to Roscilox, a brand of a Cloxacillin-based drug formulation, than that fixed by the govt under Drugs (Price Control) Order (DPCO)".

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/xqwtosY
>

Comments

Popular posts from this blog

BTS members Jin and Jungkook unveil their postcard messages to ARMY as they gear up for ‘BE’ release 

EXCLUSIVE: "She's looking beautiful in the shot and it works very well with her personality" - Dabboo Ratnani on shooting with Ananya Panday for his annual calendar

EXCLUSIVE: Tadap actress Tara Sutaria would like to raid Deepika Padukone’s wardrobe; says ‘she is very chic’